SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-18-000032
Filing Date
2018-08-22
Accepted
2018-08-22 16:37:02
Documents
4
Period of Report
2018-08-22
Effectiveness Date
2018-08-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2018.htm DEF 14A 735243
2 image1a05.jpg GRAPHIC 164429
3 ljpc2018proxycard8222018pa02.jpg GRAPHIC 324134
4 ljpc2018proxycard8222018pa03.jpg GRAPHIC 242850
  Complete submission text file 0000920465-18-000032.txt   1743650
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 181032845
SIC: 2836 Biological Products, (No Diagnostic Substances)